Issue Date: February 20, 2017 | Web Date: February 15, 2017
Avantium eyes $100 million IPO
Avantium, a 2000 spin-off from Shell with technologies for converting plant sugars into biochemicals and polymers, says it will make an initial public offering of shares on two European stock exchanges by the end of March. The firm hopes to raise just over $100 million.
It is an unusual move. Biobased chemical companies have shied away from stock offerings in recent years because biomaterial prices have been suppressed by the low price of crude oil.. . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society